| scholarly article | Q13442814 |
| P50 | author | Klaudia Skrzypek | Q59696744 |
| Anna Kusienicka | Q88584466 | ||
| Marcin Majka | Q88841239 | ||
| P2093 | author name string | Ewa Lukasiewicz | |
| Katarzyna Miekus | |||
| Tomasz Adamus | |||
| Barbara Szewczyk | |||
| P2860 | cites work | MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia | Q21092263 |
| Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression | Q24568374 | ||
| MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development | Q24648202 | ||
| MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression | Q24683830 | ||
| Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene | Q28202069 | ||
| Met, metastasis, motility and more | Q28235183 | ||
| Targeting the c-Met signaling pathway in cancer | Q28246393 | ||
| Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud | Q28506228 | ||
| Wnt activity defines colon cancer stem cells and is regulated by the microenvironment | Q29618024 | ||
| MicroRNA-378 targets the myogenic repressor MyoR during myoblast differentiation | Q30426550 | ||
| Snail1 controls bone mass by regulating Runx2 and VDR expression during osteoblast differentiation. | Q30486161 | ||
| The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation | Q30534479 | ||
| Efficient myoblast expansion for regenerative medicine use | Q33811402 | ||
| shRNA-mediated decreases in c-Met levels affect the differentiation potential of human mesenchymal stem cells and reduce their capacity for tissue repair | Q34163289 | ||
| Building muscle: molecular regulation of myogenesis. | Q34251533 | ||
| Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase | Q34358610 | ||
| Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation | Q34442918 | ||
| Conditional activation of MET in differentiated skeletal muscle induces atrophy. | Q34595811 | ||
| Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members | Q34894993 | ||
| The melanocyte differentiation program predisposes to metastasis after neoplastic transformation | Q35216430 | ||
| MET receptor is a potential therapeutic target in high grade cervical cancer | Q35832923 | ||
| CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion | Q35875566 | ||
| Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor | Q35961109 | ||
| MET is required for the recruitment of anti-tumoural neutrophils | Q36125652 | ||
| Cancer therapy: can the challenge be MET? | Q36159458 | ||
| Snail1 controls TGF-β responsiveness and differentiation of mesenchymal stem cells. | Q36388832 | ||
| Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas | Q36409237 | ||
| From Tpr-Met to Met, tumorigenesis and tubes. | Q36745364 | ||
| The biological role of HGF-MET axis in tumor growth and development of metastasis | Q36992086 | ||
| Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis | Q37087420 | ||
| The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation | Q37286651 | ||
| Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell? | Q37325228 | ||
| Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors | Q37356573 | ||
| Pax3:Fkhr interferes with embryonic Pax3 and Pax7 function: implications for alveolar rhabdomyosarcoma cell of origin. | Q37598845 | ||
| Tumor-associated neutrophils: new targets for cancer therapy | Q37856086 | ||
| Modeling sarcomagenesis using multipotent mesenchymal stem cells | Q37935534 | ||
| Targeting MET in cancer: rationale and progress | Q37978193 | ||
| Hypoxia control to normalize pathologic angiogenesis: potential role for endothelial precursor cells and miRNAs regulation | Q37996791 | ||
| MicroRNAs and epigenetic mechanisms of rhabdomyosarcoma development | Q38212020 | ||
| C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell | Q38212355 | ||
| Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival | Q38441644 | ||
| The strategy of fusion genes construction determines efficient expression of introduced transcription factors | Q38960590 | ||
| miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control. | Q39228419 | ||
| Differential expression of Snail1 transcription factor and Snail1-related genes in alveolar and embryonal rhabdomyosarcoma subtypes | Q39561634 | ||
| Myc/miR-378/TOB2/cyclin D1 functional module regulates oncogenic transformation | Q39606702 | ||
| Inhibition of rhabdomyosarcoma's metastatic behavior through downregulation of MET receptor signaling | Q39738155 | ||
| Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma | Q39966371 | ||
| Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells | Q41109580 | ||
| Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development | Q42770153 | ||
| Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma. | Q42802665 | ||
| Transcription factor Snail is a novel regulator of adipocyte differentiation via inhibiting the expression of peroxisome proliferator-activated receptor γ. | Q42819239 | ||
| A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation | Q42821276 | ||
| Functional mapping of receptor tyrosine kinases in myxoid liposarcoma. | Q43045056 | ||
| c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. | Q46265281 | ||
| Genetically modified adipose tissue-derived mesenchymal stem cells overexpressing CXCR4 display increased motility, invasiveness, and homing to bone marrow of NOD/SCID mice. | Q50524510 | ||
| Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. | Q52547784 | ||
| The MET oncogene is a functional marker of a glioblastoma stem cell subtype. | Q55462084 | ||
| Rhabdomyosarcoma spheroids with central proliferation and differentiation | Q67720758 | ||
| HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells | Q74213837 | ||
| Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations | Q81780679 | ||
| c-Met is a marker of pancreatic cancer stem cells and therapeutic target | Q84816959 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 31 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rhabdomyosarcoma | Q1898141 |
| P304 | page(s) | 31378-31398 | |
| P577 | publication date | 2015-09-08 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression | |
| P478 | volume | 6 |
| Q64060174 | C-Met as a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas |
| Q48235688 | Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-β1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets |
| Q38763225 | Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma |
| Q92600008 | MET promotes the proliferation and differentiation of myoblasts |
| Q95388147 | Rhabdomyosarcoma |
| Q55041016 | SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function. |
| Q50422607 | SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma. |
| Q26770132 | The Role of miR-378a in Metabolism, Angiogenesis, and Muscle Biology |
| Q36194212 | Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion. |
Search more.